Fierce Healthcare March 24, 2022
As COTA looks to expand its oncology real-world data and analytics expertise in healthcare and life sciences, the company tapped pharma veteran Miruna Sasu, Ph.D., as its new CEO and president.
Sasu joined the company in 2021 as chief strategy officer. Taking the helm, she will focus on accelerating growth at COTA with a focus on advancing real-world data use in drug development and building up strategic provider and clinical research partnerships to improve outcomes for cancer patients.